What is the current valuation of the Pain Management Market?

As of 2024, the Pain Management Market was valued at 75.23 USD Billion. Read More

What is the projected market size for the Pain Management Market by 2035?

The Pain Management Market is projected to reach 134.05 USD Billion by 2035. Read More

What is the expected CAGR for the Pain Management Market during the forecast period 2025 - 2035?

The expected CAGR for the Pain Management Market during the forecast period 2025 - 2035 is 5.39%. Read More

Which segment of the Pain Management Market had the highest valuation in 2024?

In 2024, the Chronic Pain segment had the highest valuation at 30.0 USD Billion. Read More

What are the key types of treatment in the Pain Management Market?

Key types of treatment include Pharmacological Treatment, Physical Therapy, and Interventional Procedures. Read More

How does the Pain Management Market segment by patient demographics?

The market segments by patient demographics include Age Group, Gender, Socioeconomic Status, Comorbidities, and Lifestyle Factors. Read More

Which route of administration is most prevalent in the Pain Management Market?

The Oral route of administration is most prevalent, with a valuation of 30.0 USD Billion in 2024. Read More

What is the market valuation for pharmacies in the Pain Management Market?

Pharmacies had a market valuation of 37.23 USD Billion in 2024. Read More

Who are the leading companies in the Pain Management Market?

Leading companies include Johnson & Johnson, Pfizer Inc., and AbbVie Inc. Read More

What is the projected growth for the Acute Pain segment by 2035?

The Acute Pain segment is projected to grow from 15.0 USD Billion in 2024 to 27.0 USD Billion by 2035. Read More

Pain Management Market

ID: MRFR/MED/4517-HCR

200 Pages

Rahul Gotadki

Last Updated: June 05, 2026

Pain Management Market Research Report By Type of Pain (Acute Pain, Chronic Pain, Neuropathic Pain, Nociceptive Pain), By Treatment Type (Medication, Physical Therapy, Interventional Procedures, Alternative Therapies), By End User (Hospitals, Clinics, Homecare Settings, Rehabilitation Centers), By Route of Administration (Oral, Topical, Injectable, Transdermal) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Aging Population & Chronic Disease Burden | |
  2. 3.1.2 Regulatory Shift Toward Multimodal Analgesia Approaches | |
  3. 3.1.3 Neuromodulation & Device Innovation | |
  4. 3.1.4 Digital Health & AI-Driven Dosing Integration | |
  5. 3.1.5 Expanding Health Insurance in Emerging Markets | |
  6. 3.1.6 CGRP-Inhibitor & Biologics Pipeline Growth | |
  7. 3.1.7 Ambulatory Surgical Center Proliferation |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 Opioid Litigation Liability & Market Stigma | |
  2. 3.2.2 High Device Acquisition Costs | |
  3. 3.2.3 Reimbursement Fragmentation for Non-Pharmacological Modalities | |
  4. 3.2.4 Clinical Evidence Gaps for Emerging Therapies | |
  5. 3.2.5 Supply Chain Constraints for Specialized Components |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Closed-Loop Neuromodulation Platforms | |
  2. 3.3.2 Prescription Digital Therapeutics Expansion | |
  3. 3.3.3 Emerging-Market Insurance Expansion | |
  4. 3.3.4 AI-Driven Dosing & Data Monetization | |
  5. 3.3.5 Ambulatory Surgical Center Migration |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Pain Management Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Mode of Pain Management | |
  1. 5.1.1 Drugs — Opioids | |
  2. 5.1.2 Drugs — Non-Narcotic Analgesics | |
  3. 5.1.3 Devices — Neuro-Modulation Devices | |
  4. 5.1.4 Devices — Other Devices |
2. 5.2 By Application | |
  1. 5.2.1 Neuropathic Pain | |
  2. 5.2.2 Cancer Pain | |
  3. 5.2.3 Facial Pain & Migraine | |
  4. 5.2.4 Other Applications |
3. 5.3 By Setting of Care | |
  1. 5.3.1 Hospitals | |
  2. 5.3.2 Ambulatory Surgical Centers | |
  3. 5.3.3 Home Care & Other Settings
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Pfizer Inc. | |
  2. 7.3.2 Johnson & Johnson (DePuy Synthes) | |
  3. 7.3.3 Abbott Laboratories | |
  4. 7.3.4 Medtronic plc | |
  5. 7.3.5 Novartis AG | |
  6. 7.3.6 Teva Pharmaceutical | |
  7. 7.3.7 Boston Scientific Corp. | |
  8. 7.3.8 Eli Lilly & Co. | |
  9. 7.3.9 Nevro Corp. | |
  10. 7.3.10 Haleon plc
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Powered Precision Pain Management |
2. 8.2 Platform Economics in Digital Therapeutics |
3. 8.3 Decentralization of Interventional Pain Procedures |
4. 8.4 ESG-Driven Capital Reallocation
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Pain Management Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Pain Management Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis — Pain Management Market, 2026–2035 |
TABLE 4 Restraint Impact Analysis — Pain Management Market, 2026–2035 |
TABLE 5 Global Pain Management Market Size, by Mode of Pain Management, 2021–2035 (USD Billion) |
TABLE 6 Global Pain Management Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 7 Global Pain Management Market Size, by Setting of Care, 2021–2035 (USD Billion) |
TABLE 8 Global Pain Management Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Pain Management Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Pain Management Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Pain Management Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Pain Management Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Pain Management Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Competitive Benchmarking Matrix — Global Pain Management Market, 2025 |
TABLE 15 Company Profiles — Key Players, Global Pain Management Market |
TABLE 16 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 17 Report Scope & Methodology Summary |
TABLE 18 Detailed Sources and Citations |
TABLE 19 North America Pain Management Market Size, by Mode of Pain Management, 2021–2035 (USD Billion) |
TABLE 20 North America Pain Management Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 21 North America Pain Management Market Size, by Setting of Care, 2021–2035 (USD Billion) |
TABLE 22 Europe Pain Management Market Size, by Mode of Pain Management, 2021–2035 (USD Billion) |
TABLE 23 Europe Pain Management Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 24 Europe Pain Management Market Size, by Setting of Care, 2021–2035 (USD Billion) |
TABLE 25 Asia-Pacific Pain Management Market Size, by Mode of Pain Management, 2021–2035 (USD Billion) |
TABLE 26 Asia-Pacific Pain Management Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 27 Asia-Pacific Pain Management Market Size, by Setting of Care, 2021–2035 (USD Billion) |
TABLE 28 South America Pain Management Market Size, by Mode of Pain Management, 2021–2035 (USD Billion) |
TABLE 29 South America Pain Management Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 30 South America Pain Management Market Size, by Setting of Care, 2021–2035 (USD Billion) |
TABLE 31 Middle East & Africa Pain Management Market Size, by Mode of Pain Management, 2021–2035 (USD Billion) |
TABLE 32 Middle East & Africa Pain Management Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 33 Middle East & Africa Pain Management Market Size, by Setting of Care, 2021–2035 (USD Billion)
13 LIST OF FIGURES |
FIGURE 1 Pain Management Market Dynamics — Drivers, Restraints & Opportunities |
FIGURE 2 Industry Value Chain Analysis — Pain Management Market |
FIGURE 3 Porter's Five Forces Analysis — Pain Management Market |
FIGURE 4 Global Pain Management Market Size Trend & Forecast (USD Billion), 2021–2035 |
FIGURE 5 Pain Management Market Share, by Mode of Pain Management (%), 2025 |
FIGURE 6 Pain Management Market Share, by Application (%), 2025 |
FIGURE 7 Pain Management Market Share, by Setting of Care (%), 2025 |
FIGURE 8 Pain Management Market Share, by Region (%), 2025 |
FIGURE 9 North America Pain Management Market Size & Forecast (USD Billion), 2021–2035 |
FIGURE 10 Europe Pain Management Market Size & Forecast (USD Billion), 2021–2035 |
FIGURE 11 Asia-Pacific Pain Management Market Size & Forecast (USD Billion), 2021–2035 |
FIGURE 12 South America Pain Management Market Size & Forecast (USD Billion), 2021–2035 |
FIGURE 13 Middle East & Africa Pain Management Market Size & Forecast (USD Billion), 2021–2035 |
FIGURE 14 Competitive Landscape — Market Share Analysis, Pain Management Market, 2025

Certified Researchers

Customize Report

SEGMENTATION QUICK REFERENCE

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
Mode of Pain Management	Drugs (Opioids, Non-Narcotic Analgesics); Devices (Neuro-Modulation Devices, Other Devices)	Drugs — Opioids	Devices — Neuro-Modulation Devices
Application	Neuropathic Pain; Cancer Pain; Facial Pain & Migraine; Other Applications	Neuropathic Pain	Facial Pain & Migraine
Setting of Care	Hospitals; Ambulatory Surgical Centers; Home Care & Other Settings	Hospitals	Home Care & Other Settings
Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

MARKET SEGMENTATION OVERVIEW

By Mode of Pain Management

Sub-Segment	Key Trend
Drugs — Opioids	Declining prescription volumes in developed markets are offset by sustained palliative care demand
Drugs — Non-Narcotic Analgesics	CGRP inhibitors and COX-2 selective agents are driving share gains as first-line therapies
Devices — Neuro-Modulation Devices	Closed-loop AI-adaptive spinal cord stimulators redefining durable pain relief standards
Devices — Other Devices	Portable TENS and radiofrequency ablation units are expanding home-care access

The mode of pain management dimension reflects a structural shift from pharmacological dependence toward device-based and hybrid treatment models. Drug revenues remain dominant by absolute value, but device growth rates outpace pharmaceuticals by a factor of two, signaling a rebalancing of the Pain Management Market over the forecast period.

By Application

Sub-Segment	Key Trend
Neuropathic Pain	The global diabetes epidemic is sustaining high treatment volumes across all care settings
Cancer Pain	Longer oncology survival is creating chronic rather than acute pain management needs
Facial Pain & Migraine	CGRP-class biologics and non-invasive neurostimulation are driving rapid commercial expansion
Other Applications	Musculoskeletal and post-operative pain anchoring baseline demand

Application-level dynamics are shaped by epidemiological trends and therapeutic innovation cycles. Neuropathic pain retains the largest share due to the sheer prevalence of diabetic peripheral neuropathy, while the facial pain and migraine segment benefits from a rich clinical pipeline and favorable reimbursement dynamics.

By Setting of Care

Sub-Segment	Key Trend
Hospitals	Complex interventional procedures and acute pain episodes concentrate revenue in inpatient settings
Ambulatory Surgical Centers	CMS reimbursement parity and lower overhead are driving procedure migration from hospitals
Home Care & Other Settings	Digital therapeutics and wearable neuromodulation enabling chronic pain management outside institutions

The care-setting dimension captures the decentralization trend reshaping the Pain Management Market. Hospitals retain dominance for complex procedures, but the fastest growth accrues to home-care settings where digital platforms and portable devices enable continuous chronic pain therapy management.

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”